RxDoctor Payments Data

Traci Cornett, APRN

Psychiatric/Mental Health · Prestonsburg, KYNPI 1679052864

Payments from drug & device makers

$6,241in general payments, 2019–2025

Across 294 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$880
  • Axsome Therapeutics, Inc.$726
  • Lundbeck LLC$522
  • Otsuka America Pharmaceutical, Inc.$454
  • Johnson & Johnson$424
  • plus $2K from 12 others

What the payments were for

  • Food & beverage$6,16799%
  • Education$741%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,241 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$2,159
Medicare patients
13
Services billed
43

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate23$200,499
Austedo XrDeutetrabenazine16$186,408
Abilify MaintenaAripiprazole26$68,930
VraylarCariprazine Hcl44$60,418
CaplytaLumateperone Tosylate24$44,242
RexultiBrexpiprazole16$37,921
LybalviOlanzapine/Samidorphan Malate15$22,407
AuvelityDextromethorphan Hbr/Bupropion11$6,134
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$1,448
Buspirone Hcl60$1,056
Olanzapine40$887
Aripiprazole13$745
Lamotrigine58$619
Duloxetine Hcl16$529
Divalproex Sodium ErDivalproex Sodium17$459

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$421$200,49923 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$361$186,40816 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$454$106,85142 claims
AbbVieVraylar$1,112$60,41844 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$880$44,24224 claims
Alkermes, Inc.Lybalvi$102$22,40715 claims
Axsome Therapeutics, Inc.Auvelity$726$6,13411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Prestonsburg

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →